DEPOMED INC - NOTE 2.500% 9/0

Historical Holders from Q2 2014 to Q3 2021

Type / Class
Debt / NOTE 2.500% 9/0
All holders as of 30 Sep 2021
Q3 2021
Total 13F principal, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of DEPOMED INC - NOTE 2.500% 9/0

Period Principal Value Change Price Investors
2021 Q3 0 $0 -$3,000 0
2021 Q2 4,000 $3,000 $0.7500 1
2021 Q1 4,000 $3,000 -$2,000 $0.7500 1
2020 Q4 6,000 $5,000 $0.8750 2
2020 Q3 6,000 $5,000 -$5,000 $0.8750 2
2020 Q2 11,000 $11,000 -$13,188,921 $1.00 3
2020 Q1 13,311,500 $13,199,921 -$79,861,562 $0.9900 11
2019 Q4 123,156,000 $90,482,819 +$477,525 $0.7396 22
2019 Q3 122,352,000 $90,590,817 -$144,652,339 $0.7447 24
2019 Q2 318,389,000 $230,024,755 +$34,453,726 $0.7240 30
2019 Q1 270,154,000 $208,283,000 -$22,370,340 $0.7700 28
2018 Q4 310,691,000 $211,591,000 +$210,411,570 $0.6769 30
2018 Q3 1,755,000 $1,385,000 -$252,336,977 $0.7892 1
2018 Q2 308,879,000 $253,763,000 +$19,234,880 $0.8169 37
2018 Q1 285,523,000 $233,895,000 -$3,988,097 $0.8146 35
2017 Q4 290,887,000 $245,713,000 +$33,161,557 $0.8440 39
2017 Q3 255,764,000 $189,634,000 -$24,894,132 $0.7417 46
2017 Q2 283,099,000 $249,751,890 -$48,948,399 $0.8809 43
2017 Q1 335,189,000 $314,681,974 -$12,314,051 $0.9385 49
2016 Q4 343,144,000 $391,852,666 +$1,782,374 $1.14 49
2016 Q3 335,292,000 $478,575,490 -$14,809,301 $1.43 48
2016 Q2 336,321,002 $405,408,308 +$19,370,310 $1.21 42
2016 Q1 335,461,000 $314,848,891 +$1,957,780 $0.9344 42
2015 Q4 325,223,000 $370,676,000 -$2,453,030 $1.14 37
2015 Q3 332,797,000 $396,598,000 -$4,119,294 $1.19 42
2015 Q2 340,297,000 $436,443,000 +$18,864,848 $1.28 42
2015 Q1 313,151,000 $414,217,716 +$27,191,681 $1.32 44
2014 Q4 278,758,000 $302,190,000 -$4,997,289 $1.08 36
2014 Q3 291,445,000 $308,479,000 +$271,430,930 $1.06 36
2014 Q2 14,500,000 $15,167,000 +$15,167,000 $1.05 1